BEONE MEDICINES LTD.
BEONE MEDICINES LTD.
BASEL
Loading...
Price History
Market Data
| Market Cap | 32.46B |
| P/E Ratio | 125.02 |
| P/B Ratio | 7.44 |
| EPS | 0.18 |
| Dividend Yield | - |
| D/E Ratio | 0.88 |
| Current Ratio | 3.41 |
| Currency | USD |
Key Financial Metrics
5.34B
Revenue
286.93M
Net Income
0.18
EPS (Diluted)
1.14B
Free Cash Flow
Profitability
Gross Margin
87.5%
Operating Margin
8.4%
Net Profit Margin
5.4%
EBITDA
690.04M
Returns & Efficiency
Return on Assets (ROA)
3.5%
Return on Equity (ROE)
6.6%
Dividend Yield
-
EPS
0.18
Financial Health
Total Assets
8.19B
Total Debt
845.43M
Debt to Equity
0.88x
Current Ratio
3.41
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | BASEL |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
281.00B
P/E: --
152.61B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$32.46B
P/E Ratio (TTM)125.0
Price to Book7.44
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin87.5%
Operating Margin8.4%
Net Margin5.4%
ROE6.6%
ROA3.5%
Leverage & Liquidity
Debt to Equity0.88
Current Ratio3.41
Total Debt$845.43M
Total Assets$8.19B
Stockholders' Equity$4.36B
Income Statement (FY 2025)
Revenue$5.34B
Gross Profit$4.67B
Operating Income$447.14M
Net Income$286.93M
EPS (Diluted)$0.18
Cash Flow (FY 2025)
Free Cash Flow$1.14B
Cash & Equivalents$4.55B
Revenue Growth40.2%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL, None 4051 |
| Phone | 41-616851900 |
| Incorporated | None, None |
| EIN | 981209416 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.44B |
| Stockholders' Equity | $4.36B |
| Cash & Equivalents | $4.55B |
Recent Filings
View All
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-28
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-28
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-28
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-04-16
Local
PRE 14A
Preliminary Proxy Statement
Preliminary proxy statement for SEC review
Filed: 2026-04-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-14
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-06
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BEONE MEDICINES LTD. |
| Ticker | BEIGF |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | BASEL |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 32.46B |
| Revenue | 5.34B |
| Net Income | 286.93M |
| P/E Ratio | 125.02 |
| EPS | 0.18 |
| Net Margin | 5.4% |
| ROE | 6.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...